Himeji, Japan

Hisashi Shinohara

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2000-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hisashi Shinohara. Retrieved from https://idiyas.com/inventor/hisashi-shinohara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 25.0


 

Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 13(Granted Patents)


Location History:

  • Gifu, JP (2000)
  • Himeji, JP (2010 - 2011)
  • Osaka, JP (2017)

Company Filing History:


Years Active: 2000-2017

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Hisashi Shinohara

Introduction

Hisashi Shinohara is a notable inventor based in Himeji, Japan. With a remarkable track record of four patents, he has contributed significantly to the field of pharmaceutical innovations. His work focuses on cyanopyrimidine compounds, which play a crucial role in developing medications that target specific receptor activities in the body.

Latest Patents

Shinohara's latest innovations include two significant patents. The first is a cyanopyrimidine derivative, which pertains to a novel cyanopyrimidine compound and a pharmaceutical composition demonstrating safe and potent adenosine A2a receptor agonistic activity. This discovery has promising implications for various therapeutic applications.

The second patent concerns 4-amino-5-cyanopyrimidine derivatives, offering potential treatment options for conditions such as glaucoma. The innovation provides 4-amino-5-cyanopyrimidine derivatives characterized by specific formulas and their pharmaceutical salts, highlighting their relevance as adenosine A2a receptor agonists and intraocular pressure-reducing agents.

Career Highlights

Hisashi Shinohara is currently affiliated with Otsuka Pharmaceutical Company, Limited, where he continues to advance his work in pharmaceutical development. His expertise in medicinal chemistry and drug development has been instrumental in creating innovative solutions for healthcare challenges.

Collaborations

Throughout his career, Shinohara has collaborated with esteemed colleagues, including Yasuhiro Takeji and Norifumi Sato. These partnerships have fostered an environment of innovation and creativity, leading to the successful development of numerous pharmaceutical compounds.

Conclusion

Hisashi Shinohara’s contributions to the field of pharmaceuticals exemplify the spirit of innovation. His dedication to developing effective therapeutic agents through his patents marks him as a significant figure in the realm of medicinal advancements. As pharmaceutical research continues to evolve, the work of inventors like Shinohara will remain pivotal in shaping the future of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…